Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
19 sept. 2024 07h00 HE | Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
12 sept. 2024 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
12 sept. 2024 16h05 HE | Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
12 sept. 2024 07h00 HE | Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
10 sept. 2024 07h00 HE | Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
09 sept. 2024 16h05 HE | Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 sept. 2024 16h05 HE | Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Logo Bioconnection.jpg
BioConnection appoints Richard Sewalt as New Chief Commercial Officer
06 sept. 2024 03h43 HE | BioConnection
OSS, The Netherlands – 6 September 2024, BioConnection, a leading Dutch contract development and manufacturing organization (CDMO) in the pharmaceutical industry, today announced the appointment of...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
05 sept. 2024 16h05 HE | Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
blue-mountain-logo-blue 1 1.png
Blue Mountain and RCM Technologies Partner to Elevate Enterprise Asset Management in Life Sciences with Pre-Validated Software and Unparalleled Domain Expertise
05 sept. 2024 09h00 HE | Blue Mountain
Blue Mountain & RCM Technologies join forces to deliver cutting-edge EAM solutions, tailored for life sciences with pre-validated software & expert service